In the present study, we demonstrate that designed chimeric TALEs (dTALEs) containing a catalytic domain of DNA methyltransferase DNMT3A or DNA demethylase TET1 can turn prostate cancer metastasis on or off by altering CRMP4 expression through locus-specific modification of the gene promoter. This evidence concerns the gene DPYSL3 and prostate carcinoma.